Tn antigen is a truncated O-glycan, frequently detected in colorectal cancer (CRC), but its precise role in CRC metastasis is not well addressed. Here we investigated the effects of Core 1 β3Gal-T specific molecular chaperone (Cosmc) deletion-mediated Tn antigen exposure on CRC metastasis and its underlying mechanism. We first used CRISPR/Cas9 technology to knockout Cosmc, which is required for nor- 
| INTRODUCTION
Colorectal cancer (CRC) is one of the most common gastrointestinal tumours and the third highest cause of cancer-related death around the world.
1,2 Distant metastasis, especially liver metastasis, is the main cause for death in patients with CRC. 3, 4 However, the mechanisms underlying cancer invasion and metastasis are less well defined. More recent studies have shown that abnormal O-glycosylation of many secreted and membrane-bound glycoproteins, resulting in expression of the immature truncated O-glycans such as Tn antigen, is strongly associated with cancer progression and metastasis in various human cancers including CRC.
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Mucin type O-glycosylation is initiated by addition of N-acetyl galactosamine (GalNAc) to either serine or threonine, thus forming a biosynthetic intermediate O-linked structure called Tn antigen. 8, 9 Tsynthase (core 1 β1,3-galactosyltransferase), a key enzyme in the Oglycosylation pathway, converts Tn antigen to more complex O-glycans that eventually modify many secreted and transmembrane glycoproteins. 10, 11 Of note, the expression and activity of T-synthase require an endoplasmic reticulum (ER)-resident molecular chaperone
Cosmc. [12] [13] [14] Dysfunction in T-synthase or Cosmc leads to the expression of Tn antigen, which is indeed a characteristic of abnormal Oglycosylation. 15, 16 It has been reported that Tn antigen is detected in almost 90% of human colon cancer whereas it is rarely detected in normal tissue. 15, 17 Tn antigen expression is correlated with tumour invasion and poor prognosis in CRC patients, and it is proposed as a potential target for immunotherapy. 6, 18 Nevertheless, it remains elusive whether Tn antigen may play a causative role in colorectal cancer development and metastasis.
In this study, we forcedly induced Tn antigen expression in both CRC cell lines (HCT116, SW480) through knockout of the Cosmc chaperone. Both in vitro and in vivo experiments showed that Tn antigen directly promoted cancer invasion and metastasis of cells or tumours, suggesting a metastasis-promoting role for Tn antigen.
Moreover, we found that Tn antigen activated the EMT process, which was responsible for the observed oncogenic alterations, by up-regulating the expression of H-Ras. 
| MATERIALS AND METHODS

| Cell culture
| CRISPR/Cas9-mediated knockout of Cosmc chaperone
The single guide RNA (sgRNA) Oligos targeting Cosmc gene were designed according to the principle of CRISPR/Cas9 system. The sgRNA sequences for human Cosmc exon1 were: F:5′-CACCGTGTGCTTTGATCACTATGCT-3′;R:5′-AAACAGCATAGTGAT-CAAAGCACAC-3′. The sgRNA sequences were cloned into linearized LentiCRISPRv2 plasmids, which were co-transfected into HEK293T cells with psPAX2 and pMD2.G plasmids using Lipofectamine 3000
(Invitrogen, Carlsbad, CA, USA) to produce lentivirus containing CRISPR/Cas9 system targeting Cosmc gene. The virus was transfected into CRC cell lines HCT116 and SW480 with polybrene (Genechem, Shanghai, China). These transfected cells were cultured for 48 h and then selected with 2 μg/mL puromycin.
| Flow cytometry
Cells were harvested from the culture flask and resuspended in 100 μL PBS (1 × 10 6 /mL). The mouse anti-Tn mAb (CA3638, clone 12A8-C7-F5, 10 μg/mL, kindly provided by Dr. Tongzhong Ju of the Emory University School of Medicine in Altanta, USA) was used to detect the expression of Tn antigen. After incubation at 4°C for 1 hour, the cells were incubated with PE-labelled goat antimouse IgM (BD, 562033) for 60 minutes at 4°C. Then the cells were washed twice and then analysed using the flow cytometer (Canto II; BD Bioscience, Franklin Lakes, NJ, USA). 
| Cell migration and invasion assays
| Establishment of transplantable metastatic murine models
The male BALB/c nude mice aged 6 weeks were purchased from Charles River Laboratories (Beijing, China) and maintained under specific pathogen-free conditions. All animal experiments were per- mouse) were injected into the spleen of each mouse (n = 6 for each group) respectively. After 8 weeks, the mice were killed and the livers and lungs were excised and fixed with formalin for H&E staining.
For orthotopic implantation models, 2 × 10 6 HCT116Tn+ cells or HCT116Tn-cells were first injected subcutaneously into 6-week-old BALB/c nude mice to attain subcutaneous xenografts that were subsequently minced into 2 mm 3 pieces and subserosally transplanted into the cecum of other mice (n = 5 for each group). When cachexia occurred, the mice were killed. The xenografts and macroscopically visible metastatic lymph nodes were isolated and embedded in paraffin for histological examinations and immunohistochemistry staining.
| Immunohistochemistry
The prepared paraffin-embedded tissues were cut into 5 μm thick sections that were subsequently dewaxed and rehydrated. After antigen retrieval and blocking endogenous peroxidase, the sections were incubated with specific primary antibody against Tn antigen 
| Re-expression of Cosmc in LS174T cells
The GV367-EGFP-Cosmc lentiviral particles were produced by Shanghai Genechem Co. Ltd (Shanghai, China) . LS174T cells were transfected with the lentiviral particles with or without a Cosmc gene insert using polybrene (Genechem). The transfected cells were selected using puromycin (2 μg/mL) after 2 days and then pooled for further studies.
| RNA extraction and quantitative real-time PCR
Total RNA was isolated from cells and tissues from xenografts using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. The complementary DNA was synthesized using Prime Script TM RT Master Mix (TaKaRa, Dalian, China). The mRNA levels were detected by Real-time PCR analyses using SYBR Premix (Applied Biosystems, Foster, CA, USA) on the 7500 Sequence Detection System (Applied Biosystems) with GAPDH identified as an internal control. The sequences of primers used were shown in Table S1 .
Relative changes in mRNA were normalized with GAPDH and calculated using 2 -▵▵CT methods.
| Western blotting and antibodies
Cells and tissues from xenografts were lysed with RIPA lysis buffer (Solarbio, Shanghai, China) and the protein concentration was determined by BCA assay kit (Thermo Fischer, Waltham, MA, USA).
Equal amount of denatured protein was electrophoresed on 10% SDS- 
| TCGA colon cancer dataset
To depict the association between Cosmc and H-Ras in CRC patients, the RNA-seq data of the 438 cases from TCGA colon cancer dataset were obtained from the cBioPortal for Cancer Genomics (http://www.cbioportal.org/).
| Statistical analysis
Each experiment was repeated three times independently to verify reproducibility. Data analysis was performed using the SPSS 22.0 statistical software. The data from in vitro experiments were presented as the mean ± SD. The differences of survival time between the mice bearing Tn-positive cells and the mice bearing Tn-negative cells in the orthotopic models was evaluated using a log-rank test.
The none-parametric Mann-Whitney U test was used when the metastasis rate between two groups was compared. Student's t test was used for the statistical analysis. P < 0.05 was considered statistically significant.
| RESULTS
| Cosmc deficiency induces the expression of Tn antigen in human CRC cell lines
To explore the roles of Tn antigen, we first used CRISPR/Cas9 technology to knockout the gene encoding Cosmc, which is specifically 
| Tn antigen promotes invasive and metastatic properties of colorectal cancer
We conducted the transwell assays (matrigel-uncoated for migration We also established an orthotopic implantation murine model, which ideally mimics the in vivo invasion and metastasis of cancer, to investigate the effects of Tn antigen on CRC metastasis. 19, 20 Although there was no liver or lung metastasis detected in the mice undergoing orthotopic transplantation, we still observed that the mice implanted with Tn-positive cells presented with more lymph node metastases compared with those implanted with Tn-negative cells (5/5, 100% vs 3/5, 60%) ( Figure 2F and Figure S1 ). Besides, Tn antigen led to a significantly reduced survival time in the mice bearing Tn-positive xenotransplants (P = 0.047) ( Figure 2G and Table S2 ).
Collectively, Tn antigen expression significantly enhanced the in vivo metastasis of CRC (9 of 11 vs 4 of 11, P = 0.034, Figure 3D ). Together, these data indicated that Tn antigen expression was able to activate the EMT process in CRC.
| Tn antigen targets H-Ras to activate the EMT process
We further investigated the mechanisms by which Tn antigen activates EMT. Accumulating evidence shows that Ras signalling activates EMT during cancer metastasis. 24, 25 We reasoned whether Tn antigen has an influence on Ras family proteins (H-Ras, K-Ras and NRas), and consequently, activates EMT. We found that H-Ras, but not K-ras or N-ras, was prominently up-regulated in both Tn-positive CRC cells as compared with that in Tn-negative cells ( Figure 4A and 
| Determination of Tn antigen-H-Ras signalling in patients
As these experiments indicated that Tn antigen expression was associated with H-Ras mediated EMT, we further investigated 438 cases in the TCGA cohort to delineate the relationship between Tn antigen and H-Ras in patients. Because expression of Tn antigen was induced by Cosmc deficiency, we performed a correlation analysis between Cosmc and H-Ras using the transcriptome data of colon cancer samples in TCGA. As it can be seen, Cosmc expression levels showed a significant reverse correlation with H-Ras levels (r = −0.29, P < 0.0001, Figure 6A ) in the colon cancer tissues. The expression levels of H-Ras in Cosmc-low patients were significantly higher compared with the Cosmc-high patients (P < 0.0001, Figure 6B ). All these data were consisted with the above in vitro and in vivo results and highlighted the significance of Tn antigen-H-Ras signalling in patients.
| DISCUSSION
In this study, we investigated the pathological role of Tn antigen in colorectal cancer metastasis using in vitro and in vivo experiments.
We used precise gene editing to knockout the Cosmc chaperone to It has been well documented that Tn antigen is one of the most expressed tumour antigen found in many human cancers, such as colon, 27 breast, 28 34 Hofmann et al demonstrated that forced expression of Tn antigen in pancreatic cancer cells leads to increased migration and decreased proliferation and apoptosis. 35 Lin et al also found that Tn expression in oral squamous cell carcinoma enhances the invasive potential of tumour cells through up-regulating EGFR phosphorylation and activity. 36 Conversely, Bergstrom and colleagues unexpectedly found that Tn antigen is not involved with cancer progression in a murine model of colorectal cancer; instead intestinal inflammation is a major mechanism responsible for tumour development. 37 Song et al even reported that Tn antigen expression suppressed breast cancer development in mice via impairment of MUC1 expression, which is usually highly expressed in various cancers. 38 All of these findings suggest that the role of Tn antigen in cancer progression and metastasis needs to be further understood.
In the process of O-glycosylation, the Tn antigen is normally modified to form elongated and complex O-glycans by a specific galactosyltransferase (T-synthase) in the Golgi apparatus of cells and is thereby not detectable in normal tissues. 14,39 T-synthase and its unique chaperone Cosmc are indispensable for normal O-glycosylation. 13, 40 As many studies revealed that dysfunction in Cosmc 42, 43 ) confirmed that tumour metastasis was more evident in Tn-positive group compared with the control mice expressing no Tn antigen. These findings provide direct evidence that Tn antigen promotes CRC metastasis, which may be considered as a target for immunotherapy in future.
We next asked how Tn antigen affects cancer metastasis in CRC.
Because of tumour metastasis is a complicated and multi-step course in which EMT has been considered to be associated with the increased invasive and metastatic properties, [44] [45] [46] we assumed that activation of EMT may play an important role in Tn antigen-induced metastasis. We found that Tn antigen significantly activated the EMT pathway, demonstrated by a reduced expression of epithelial cell marker such as E-cadherin, and an enhanced expression of mesenchymal cell markers with both in vitro and in vivo assays. We thereby concluded that Tn antigen promotes cancer metastasis through activation of the EMT pathway. We further explored the mechanism as to how Tn antigen activates EMT.
More recently, it has been reported that Ras/MAPK signalling pathway is responsible for activation of EMT, and is associated with tumourigenesis. 24, 47, 48 Suppression of Ras signalling by Rnd1 inhibited the following signalling cascades and consequently deregulated the activation of EMT. 49 We checked the expression profiles of Ras genes (H-Ras, K-Ras, N-Ras) in Tn-positive vs Tn-negative CRC cells, and found an increased expression of H-Ras in cancer cells expressing Tn antigen, whereas the changes of K-Ras or N-Ras were not different. Several studies revealed that ectopic expression of oncogenic H-Ras led to an EMT and increased invasive ability, which were indeed consistent with our observations. 25, 50 We found that knockdown of H-Ras resulted in a suppression of EMT and reduced the ability of cell migration and invasion, suggesting that H-Ras could be a key factor responsible for Tn antigen-induced cancer metastasis. 
